Veri Medtech Holdings, Inc. (VRHI) — SEC Filings
Veri Medtech Holdings, Inc. (VRHI) — 2 SEC filings. Latest: S-1/A (Dec 10, 2025). Sentiment: bearish. Includes 1 S-1/A, 1 S-1. Overall sentiment: bearish.
View Veri Medtech Holdings, Inc. on SEC EDGAR
Overview
Veri Medtech Holdings, Inc. (VRHI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-1/A filed on Dec 10, 2025: Veri MedTech Holdings, Inc. (VRHI) filed an S-1/A on December 10, 2025, for a firm commitment public offering of its common stock, aiming to list on The NYSE American Market. The company, operating through its wholly-owned subsidiary Veriheal Inc., generated approximately $17 million in revenue from
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 2 bearish. The dominant filing sentiment for Veri Medtech Holdings, Inc. is bearish.
Filing Type Overview
Veri Medtech Holdings, Inc. (VRHI) has filed 1 S-1/A, 1 S-1 with the SEC between Nov 2025 to Dec 2025.
Recent SEC Filings (2)
| Date | Form | Description | Risk |
|---|---|---|---|
| Dec 10, 2025 | S-1/A | Veri MedTech Files S-1/A for NYSE American Listing, Revenue Dips | high |
| Nov 14, 2025 | S-1 | Veri MedTech Launches IPO Amid Revenue Dip, Eyes NYSE Listing | high |
Risk Profile
Risk Assessment: Of VRHI's 2 recent filings, 2 were flagged as high-risk, 0 as medium-risk, and 0 as low-risk. The overall risk profile suggests elevated risk that warrants close monitoring.
Key Executives
- Joshua Green
- Samuel Adetunji
Industry Context
The medical cannabis industry continues to evolve, with increasing patient demand and a complex, fragmented regulatory landscape across different states. VRHI operates in the service segment, facilitating patient access to medical cannabis through card services and physician consultations. Competition is growing from both direct service providers and ancillary technology platforms.
Top Tags
Medical Cannabis (2) · IPO (2) · Emerging Growth Company (2) · S-1/A Filing (1) · Telehealth (1) · OTC Market (1) · NYSE American (1) · S-1 Filing (1) · Healthcare Technology (1) · Smaller Reporting Company (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| 2024 Revenue | $17M | Revenue from medical marijuana card services, down from $22M in 2023 |
| 2023 Revenue | $22M | Revenue from medical marijuana card services |
| Medical Marijuana Card Fee | $100-$200 | Fee range for each card and annual renewals |
| MarijuanaDoctors.com Acquisition Cost | $3,000,000 | Cost to acquire patient generation source in 2022 |
| Full-time Employees | 25 | Number of full-time employees as of the prospectus date |
| Last Reported Stock Price | $1.60 | VRHI's stock price on OTCID as of December 5, 2025 |
| Underwriter's Warrants | 8% | Right to purchase 8% of shares sold in offering |
| Underwriter's Warrants Exercise Price | 110% | Exercise price relative to offering price |
| Underwriter Expense Reimbursement Cap | $150,000 | Maximum reimbursement for underwriter's expenses |
| Over-allotment Option Period | 45-day | Duration for underwriter to purchase additional shares |
| Revenue from medical marijuana card services | $17M | For the year ended December 31, 2024, a decrease from $22 million in 2023. |
| Fee for medical marijuana cards | $100 to $200 | Range of fees charged for each card and annual renewals. |
| Acquisition cost | $3,000,000 | Amount paid for MarijuanaDoctors.com in 2022. |
| Full-time employees | 25 | As of the date of the prospectus, serving in various departments. |
| Liability insurance coverage | $3M | For liabilities arising from operations. |
Frequently Asked Questions
What are the latest SEC filings for Veri Medtech Holdings, Inc. (VRHI)?
Veri Medtech Holdings, Inc. has 2 recent SEC filings from Nov 2025 to Dec 2025, including 1 S-1/A, 1 S-1. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of VRHI filings?
Across 2 filings, the sentiment breakdown is: 2 bearish. The dominant sentiment is bearish.
Where can I find Veri Medtech Holdings, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Veri Medtech Holdings, Inc. (VRHI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Veri Medtech Holdings, Inc.?
Financial highlights for Veri Medtech Holdings, Inc. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for VRHI?
The investment thesis for VRHI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Veri Medtech Holdings, Inc.?
Key executives identified across Veri Medtech Holdings, Inc.'s filings include Joshua Green, Samuel Adetunji.
What are the main risk factors for Veri Medtech Holdings, Inc. stock?
Of VRHI's 2 assessed filings, 2 were flagged high-risk, 0 medium-risk, and 0 low-risk.
What are recent predictions and forward guidance from Veri Medtech Holdings, Inc.?
Forward guidance and predictions for Veri Medtech Holdings, Inc. are extracted from SEC filings as they are enriched.